WIN partners with manufacturers, physicians, hospitals, and surgery centers to effectively manage patient care and cost containment on spinal cord stimulators and other implantable orthopedic devices. This acquisition is part of Orchid Medical’s overall strategy to expand quality programs that significantly reduce the cost of implantable surgical devices to workers’ compensation payors.
More Articles on Orthopedic Devices:
Spinal Device Forecast Shows Big Opportunity in Emerging Markets
Southern Vermont Orthopaedics Now Offers Oxford Partial Knee System
Sports Medicine Device Market to Climb to $5.7B by 2017
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.